These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23136844)

  • 41. UV imaging in pharmaceutical analysis.
    Østergaard J
    J Pharm Biomed Anal; 2018 Jan; 147():140-148. PubMed ID: 28797957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and characterization of a laminar flow-through dissolution apparatus: Comparison of hydrodynamic conditions to those of common dissolution techniques.
    Greco K; Bergman TL; Bogner R
    Pharm Dev Technol; 2011 Feb; 16(1):75-87. PubMed ID: 20105086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative evaluation of various solubility enhancement strategies for furosemide.
    Murtaza G; Khan SA; Najam-ul-Haq M; Hussain I
    Pak J Pharm Sci; 2014 Jul; 27(4):963-73. PubMed ID: 25015467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. UV Raman spectroscopic study on TiO2. I. Phase transformation at the surface and in the bulk.
    Zhang J; Li M; Feng Z; Chen J; Li C
    J Phys Chem B; 2006 Jan; 110(2):927-35. PubMed ID: 16471625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Biorelevant Media Components on Dissolution Behaviour of 1,2,4-Thiadiazole Derivative Designed for Alzheimer's Disease Prevention.
    Promzeleva M; Chislov M; Volkova T; Proshin A; Kumeev R; Terekhova I
    Chem Biodivers; 2018 Feb; 15(2):. PubMed ID: 29427367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products.
    Yu LX; Wang JT; Hussain AS
    AAPS PharmSci; 2002; 4(1):E1. PubMed ID: 12049485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
    Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant.
    Sheng JJ; Kasim NA; Chandrasekharan R; Amidon GL
    Eur J Pharm Sci; 2006 Nov; 29(3-4):306-14. PubMed ID: 16982177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and application of a biorelevant dissolution method using USP apparatus 4 in early phase formulation development.
    Fang JB; Robertson VK; Rawat A; Flick T; Tang ZJ; Cauchon NS; McElvain JS
    Mol Pharm; 2010 Oct; 7(5):1466-77. PubMed ID: 20701327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. UV-visible spectroscopy as an alternative to liquid chromatography for determination of everolimus in surfactant-containing dissolution media: a useful approach based on solid-phase extraction.
    Kamberi M; Tran TN
    J Pharm Biomed Anal; 2012 Nov; 70():94-100. PubMed ID: 22726455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined SAXS/UV-vis/Raman as a diagnostic and structure resolving tool in materials and life sciences applications.
    Haas S; Plivelic TS; Dicko C
    J Phys Chem B; 2014 Feb; 118(8):2264-73. PubMed ID: 24484407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.
    Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J
    Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y; Jantratid E; Dressman JB
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of dissolution time and coating thickness of sustained release formulations using Raman spectroscopy and terahertz pulsed imaging.
    Müller J; Brock D; Knop K; Axel Zeitler J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Apr; 80(3):690-7. PubMed ID: 22245221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new approach to dissolution testing by UV imaging and finite element simulations.
    Boetker JP; Rantanen J; Rades T; Müllertz A; Ostergaard J; Jensen H
    Pharm Res; 2013 May; 30(5):1328-37. PubMed ID: 23307418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles.
    Maggio RM; Castellano PM; Kaufman TS
    Eur J Pharm Sci; 2008 May; 34(1):66-77. PubMed ID: 18394869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some factors affecting properties and dissolution behavior of tableted furosemide microspheres.
    Akbuğa J
    Pharmazie; 1992 Feb; 47(2):128-31. PubMed ID: 1635921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects.
    Vertzoni M; Fotaki N; Kostewicz E; Stippler E; Leuner C; Nicolaides E; Dressman J; Reppas C
    J Pharm Pharmacol; 2004 Apr; 56(4):453-62. PubMed ID: 15099440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.